Mahvish Muzaffar

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Antonio D’Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida et al. · Hepatology · 2022 · 218 citations · Full text

Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort

Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H. Owen et al. · Cancer Immunology Immunotherapy · 2020 · 93 citations · Full text

Cancer Epidemiology, Pooled Exploratory Analysis, Medicine +8

Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA

Reshma Jagsi, Kent A. Griffith, Eleanor Harris et al. · Journal of Clinical Oncology · 2023 · 86 citations · Full text

The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma

Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri et al. · Cancers · 2021 · 78 citations · Full text

Post-Treatment Symptoms of Pain, Anxiety, Sleep Disturbance, and Fatigue in Breast Cancer Survivors

Ann M. Schreier, Lee Ann Johnson, Nasreen A. Vohra et al. · Pain Management Nursing · 2018 · 77 citations

Nursing, Post-treatment Symptoms, Breast Oncology +11